Ticker
SCPHCompany Name
SCPHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 80.25M | $ 40.81M | 50.85% |
3/31/2025 | $ 90.96M | $ 57.54M | 63.26% |
12/31/2024 | $ 107.52M | $ 75.66M | 70.36% |
9/30/2024 | $ 125.07M | $ 91.48M | 73.15% |
6/30/2024 | $ 65.46M | $ 38.5M | 58.82% |
3/31/2024 | $ 78.45M | $ 58.45M | 74.5% |
12/31/2023 | $ 94.48M | $ 46.81M | 49.55% |
9/30/2023 | $ 106.1M | $ 35.04M | 33.03% |
6/30/2023 | $ 114.17M | $ 71.35M | 62.49% |
3/31/2023 | $ 127.37M | $ 75.45M | 59.24% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for SCPHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 44.46M ] / Assets [ $ 116.96M ]
(=) Cash to Assets [ 38.01% ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.8% |
average | 9.79% |
median | 6.44% |
std | 9.55% |